| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/21/2001 | US6277380 Measles virus mutant antigen |
| 08/21/2001 | US6277377 Using the polypeptide to screen a plurality of molecules to identify at least one molecule which specifically binds the polypeptide |
| 08/21/2001 | US6277367 Erythropoietin solution preparation |
| 08/21/2001 | US6277356 Somatostatin peptides, use as a radiopharmaceutical, e.g. for radiotherapy of somatostatin receptor tumors, complexed with y90 |
| 08/21/2001 | CA2183546C Transgenic fibrinogen |
| 08/21/2001 | CA2174315C Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/21/2001 | CA2126138C Transgenic fish and vectors therefor |
| 08/21/2001 | CA2121889C Production and use of multimeric hemoglobins |
| 08/21/2001 | CA2097916C Subunit papillomavirus vaccine and peptides for use therein |
| 08/21/2001 | CA2090969C Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| 08/21/2001 | CA2059167C Expression of human serum albumin in pichia pastoris |
| 08/16/2001 | WO2001059459A2 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | WO2001059458A1 Specific monoclonal antibody against terbinafine |
| 08/16/2001 | WO2001059456A2 Compounds for detection of infection by chlamydophila abortus |
| 08/16/2001 | WO2001059453A2 Biosensor compositions and methods of use |
| 08/16/2001 | WO2001059158A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/16/2001 | WO2001059155A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059146A1 Insecticidal compounds and methods for selection thereof |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059131A2 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells |
| 08/16/2001 | WO2001059124A1 Microplate fluorescent screening method for detecting gene anomaly allowing convenient and less expensive treatment of specimens on mass scale |
| 08/16/2001 | WO2001059123A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
| 08/16/2001 | WO2001059122A1 Dehiscence gene and methods for regulating dehiscence |
| 08/16/2001 | WO2001059121A1 Dehiscence gene and methods for regulating dehiscence |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059118A1 43239, a gpcr-like molecule and uses thereof |
| 08/16/2001 | WO2001059117A2 Seven-transmembrane proteins/g-protein coupled receptors |
| 08/16/2001 | WO2001059116A2 19459 protein, a human g-protein coupled seven transmembrane receptor |
| 08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059114A2 Tumor suppressor gene, p47ing3 |
| 08/16/2001 | WO2001059113A2 G-protein coupled receptor proteins and nucleic acids encoding same |
| 08/16/2001 | WO2001059111A1 18057 protein, a seven transmembrane protein |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059109A1 39406 protein, a seven transmembrane protein |
| 08/16/2001 | WO2001059108A2 Inhibitors of apoptosis |
| 08/16/2001 | WO2001059107A1 Novel scavenger receptors |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059105A1 Cysteinyl leukotriene receptor 2 (cysl t2) |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059094A2 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 08/16/2001 | WO2001059093A2 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
| 08/16/2001 | WO2001059089A2 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | WO2001059077A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | WO2001059070A1 Production method of recombinant rotavirus structural proteins and vaccine composition |
| 08/16/2001 | WO2001059066A2 Protein design automation for protein libraries |
| 08/16/2001 | WO2001059065A2 Novel molecules of the card-related protein family and uses thereof |
| 08/16/2001 | WO2001059064A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001058957A2 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058953A2 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function |
| 08/16/2001 | WO2001058952A2 Constitutively open voltage-gated k+ channels and methods for discovering modulators thereof |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058950A1 Improved interleukin 10 |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058948A2 USE OF NEUREGULIN-β AS AN INDICATOR AND/OR TARGET |
| 08/16/2001 | WO2001058947A1 Lipophilin complexes for use in cancer diagnosis and therapy |
| 08/16/2001 | WO2001058946A2 Polynucleotides and polypeptides encoded thereby |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 08/16/2001 | WO2001058943A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 08/16/2001 | WO2001058942A1 Antimicrobial peptides isolated from the skin of the hyperoliid frog, kassina senegalensis |
| 08/16/2001 | WO2001058941A1 Cytokine activity regulator molecules from tick salivary glands |
| 08/16/2001 | WO2001058940A2 Adenoviral capsid containing chimeric protein ix |
| 08/16/2001 | WO2001058939A2 Novel invertase inhibitors and methods of use |
| 08/16/2001 | WO2001058938A2 Human neurexin-like proteins and polynucleotides encoding the same |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058930A1 Par4 peptides and polypeptides |
| 08/16/2001 | WO2001058922A2 Method and compositions for treating hepatocellular cancer |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058494A2 Gene therapy for treating ocular-related disorders |
| 08/16/2001 | WO2001058493A1 Conjugates of follicle stimulating hormones |
| 08/16/2001 | WO2001058484A2 Novel uses of mammalian ccr8 receptors and related reagents |
| 08/16/2001 | WO2001058481A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 08/16/2001 | WO2001058479A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | WO2001058472A2 Botulinum toxin pharmaceutical compositions |
| 08/16/2001 | WO2001058467A1 Extraction of zein protein from gluten meal |
| 08/16/2001 | WO2001058462A2 Models, methods and materials relating to clinical conditions associated with reactive oxygen species |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001027282A8 Plant virus particles with exogenous internal eitopes |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 08/16/2001 | WO2001021645A3 Target for antiviral therapy |
| 08/16/2001 | WO2001016605A3 Identifying modulators of transcriptional activator protein interactions |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010891A3 Il-16 antagonists |
| 08/16/2001 | WO2001009347A3 Archaeal replication accessory factors and methods of use |
| 08/16/2001 | WO2001009303A3 Flt-3 LIGAND-ENCODING POLYNUCLEOTIDE AS A POLYNUCLEOTIDE-BASED VACCINE ENHANCER |
| 08/16/2001 | WO2001009185A3 Transmembrane transport proteins, nucleic acids encoding them and uses therefor |
| 08/16/2001 | WO2001009173A3 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 08/16/2001 | WO2001009172A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001007591A3 Dna sequences which code export systems |
| 08/16/2001 | WO2001006989A3 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |